EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT

被引:1
|
作者
Nathan, Steven [1 ]
Bradley, Sarah [1 ]
Costabel, Ulrich [1 ]
Albera, Carlo [1 ]
Behr, Juergen [1 ]
Wuyts, Wim [1 ]
Kirchgaessler, Klaus-Uwe [1 ]
Stauffer, John [1 ]
Morgenthien, Elizabeth [1 ]
Yang, Ming [1 ]
Limb, Susan [1 ]
Noble, Paul [1 ]
机构
[1] Inova Fairfax Hosp, Annandale, VA USA
关键词
D O I
10.1016/j.chest.2018.08.394
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:432A / 433A
页数:2
相关论文
共 50 条
  • [31] Air Pollution Exposure, Lung Function And Dyspnea In Patients With Idiopathic Pulmonary Fibrosis
    Johannson, K. A.
    Vittinghoff, E.
    Morisset, J.
    Wolters, P. J.
    Noth, E. M.
    Balmes, J. R.
    Collard, H. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
    van Manen, Mirjam J. G.
    Birring, Surinder S.
    Vancheri, Carlo
    Vindigni, Virginia
    Renzoni, Elisabetta
    Russell, Anne-Marie
    Wapenaar, Monique
    Cottin, Vincent
    Wijsenbeek, Marlies S.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (04)
  • [33] Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
    Glassberg, Marilyn K.
    Wijsenbeek, Marlies S.
    Gilberg, Frank
    Petzinger, Ute
    Kirchgaessler, Klaus-Uwe
    Albera, Carlo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [34] Effect Of Pirfenidone On Cough In Patients With Idiopathic Pulmonary Fibrosis
    Van Manen, M. J. G.
    Birring, S. S.
    Vancheri, C.
    Vindigni, V.
    Wapenaar, M.
    Cottin, V.
    Wijsenbeek, M. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [35] Pulmonary Rehabilitation Improves Exercise Capacity And Function In Patients With Idiopathic Pulmonary Fibrosis
    Kramer, M.
    Vainshelboim, B.
    Oliveira, J.
    Yohoshua, L.
    Wais, I.
    Rusanov, V.
    Fruchter, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [36] IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
    Duck, Annette
    Pigram, Lucy
    Errhalt, Peter
    Ahmed, Deeba
    Chaudhuri, Nazia
    ADVANCES IN THERAPY, 2015, 32 (02) : 87 - 107
  • [37] HEPATIC DISORDERS OF PIRFENIDONE OR NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) A SYSTEMATIC REVIEW
    Singla, D.
    Mahapatra, S.
    Dey, A.
    John, A.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [38] Effect of Pirfenidone on IPF-Related Mortality Outcome Measures in Patients With Idiopathic Pulmonary Fibrosis (IPF): Pooled Data Analysis From the ASCEND and CAPACITY Trials
    Nathan, Steven
    Albera, Carlo
    Bradford, Williamson
    Kardatzke, David
    Costabel, Ulrich
    du Bois, Roland
    Glaspole, Ian
    Glassberg, Marilyn
    King, Talmadge
    Kirchgaessler, Klaus-Uwe
    Lancaster, Lisa
    Lederer, David
    Pereira, Carlos
    Swigris, Jeffrey
    Valeyre, Dominique
    Noble, Paul
    CHEST, 2015, 148 (04)
  • [39] Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Results of a Responder Analysis
    Harari, S.
    Nathan, S. D.
    Behr, J.
    Wuyts, W. A.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [40] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40